Cidara Therapeutics Inc (CDTX) — Cash Flow Reinvestment Rate
Latest as of June 2023:
0.08x
Cidara Therapeutics Inc (CDTX) has a Cash Flow Reinvestment Rate of 0.08x as of June 2023, reinvesting $214.00K (capex $107.00K plus investments $-107.00K) from operating cash flow of $2.82 Million. See CDTX free cash flow to operating cash ratio to measure how efficiently the company converts operating cash flow to free cash.
Reinvestment Rate
0.08x
(Capex + Investments) / Operating CF
Total Reinvested
$214.00K
Capex + Investments
Operating Cash Flow
$2.82 Million
USD
Capital Expenditures
$107.00K
USD
Annual Cash Flow Reinvestment Rate for Cidara Therapeutics Inc (None–None)
Year-by-year capital reinvestment analysis for Cidara Therapeutics Inc. See CDTX financial flexibility score to measure the company's free cash flow as a share of total liabilities.
| Year | Reinvestment Rate | Total Reinvested (USD) | Operating CF | Capex | YoY Change |
|---|
Cash Flow Reinvestment Rate = (ABS(Capex) + ABS(Investments)) / Operating Cash Flow